Key result
The engineered LbCas12a mutant (K595A) exhibited a 2-3 times faster reaction speed and a 1,000-10,000 times increase in sensitivity compared to wild-type Cas12a.
Why the study?
The performance of CRISPR-Cas12a is not optimal when combined with isothermal amplification for pathogen detection.
Does the LbCas12a K595A mutant improve reaction speed and sensitivity for pathogen detection compared to wild-type Cas12a?
Does the LbCas12a K595A mutant improve reaction speed and sensitivity for pathogen detection compared to wild-type Cas12a?
The engineered LbCas12a K595A mutant significantly enhances the speed and sensitivity of CRISPR-based one-pot reactions for pathogen detection.
May enable faster point-of-care pathogen detection; extends Cas12a tools but leaves clinical validation open.
CRISPR-Cas12a holds promising potential for pathogen detection. However, its performance is not optimal when combined with isothermal amplification. Hence, we engineered a mutant of LbCas12a (K595A) with reduced cis -cleavage activity, to minimize interference with isothermal amplification. Compared to wild-type Cas12a, the K595A mutant exhibited a 2–3 times faster reaction speed and a 1,000–10,000 times increase in sensitivity in a one-pot reaction. We applied this mutant for detection of African Swine Fever Virus (ASFV). This K595A mutant successfully detected all 30 ASFV samples within 20 minutes. Our study suggests a universal approach to improve the performance of Cas12a for pathogen detection. • We developed LbCas12a variants to enhance performance in CRISPR-based one-pot reactions by targeting its canonical PAM. • This mutation is conserved across various Cas12a family members. • The conserved mutation suggests that this approach could universally enhance one-pot reactions involving Cas12a.
No takes yet. Share an insight, caveat, or question.
Tong et al. (2025) studied African Swine Fever Virus (ASFV) (n=30). LbCas12a mutant (K595A) vs. wild-type Cas12a was evaluated on Reaction speed and sensitivity in a one-pot reaction (2-3 times faster reaction speed and 1,000-10,000 times increase in sensitivity). The engineered LbCas12a mutant (K595A) exhibited a 2-3 times faster reaction speed and a 1,000-10,000 times increase in sensitivity compared to wild-type Cas12a.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: